SLM2 Is A Novel Cardiac Splicing Factor Involved in Heart Failure due to Dilated Cardiomyopathy

MLA

Jes-Niels Boeckel, et al. “SLM2 Is A Novel Cardiac Splicing Factor Involved in Heart Failure Due to Dilated Cardiomyopathy.” Genomics, Proteomics & Bioinformatics, vol. 20, no. 1, Feb. 2022, pp. 129–46. EBSCOhost, https://doi.org/10.1016/j.gpb.2021.01.006.

APA

Jes-Niels Boeckel, Maximilian Möbius-Winkler, Marion Müller, Sabine Rebs, Nicole Eger, Laura Schoppe, Rewati Tappu, Karoline E. Kokot, Jasmin M. Kneuer, Susanne Gaul, Diana M. Bordalo, Alan Lai, Jan Haas, Mahsa Ghanbari, Philipp Drewe-Boss, Martin Liss, Hugo A. Katus, Uwe Ohler, Michael Gotthardt, … Benjamin Meder. (2022). SLM2 Is A Novel Cardiac Splicing Factor Involved in Heart Failure due to Dilated Cardiomyopathy. Genomics, Proteomics & Bioinformatics, 20(1), 129–146. https://doi.org/10.1016/j.gpb.2021.01.006

Chicago

Jes-Niels Boeckel, Maximilian Möbius-Winkler, Marion Müller, Sabine Rebs, Nicole Eger, Laura Schoppe, Rewati Tappu, et al. 2022. “SLM2 Is A Novel Cardiac Splicing Factor Involved in Heart Failure Due to Dilated Cardiomyopathy.” Genomics, Proteomics & Bioinformatics 20 (1): 129–46. doi:10.1016/j.gpb.2021.01.006.